KYORIN Holdings, Inc. (4569.T)

JPY 1440.0

(-0.89%)

Total Assets Summary of KYORIN Holdings, Inc.

  • KYORIN Holdings, Inc.'s latest annual total assets in 2023 was 177.67 Billion JPY , up 0.93% from previous year.
  • KYORIN Holdings, Inc.'s latest quarterly total assets in 2024 Q1 was 179.91 Billion JPY , up 1.26% from previous quarter.
  • KYORIN Holdings, Inc. reported annual total assets of 176.04 Billion JPY in 2022, up 2.4% from previous year.
  • KYORIN Holdings, Inc. reported annual total assets of 171.92 Billion JPY in 2021, up 2.87% from previous year.
  • KYORIN Holdings, Inc. reported quarterly total assets of 176.17 Billion JPY for 2023 Q2, up 2.11% from previous quarter.
  • KYORIN Holdings, Inc. reported quarterly total assets of 178.94 Billion JPY for 2023 Q3, up 1.57% from previous quarter.

Annual Total Assets Chart of KYORIN Holdings, Inc. (2023 - 2004)

Historical Annual Total Assets of KYORIN Holdings, Inc. (2023 - 2004)

Year Total Assets Total Assets Growth
2023 177.67 Billion JPY 0.93%
2022 176.04 Billion JPY 2.4%
2021 171.92 Billion JPY 2.87%
2020 167.12 Billion JPY -2.36%
2019 171.16 Billion JPY -1.08%
2018 173.03 Billion JPY -12.76%
2017 198.35 Billion JPY 2.95%
2016 192.66 Billion JPY -2.61%
2015 197.82 Billion JPY 7.88%
2014 183.38 Billion JPY 8.27%
2013 169.37 Billion JPY 9.3%
2012 154.96 Billion JPY 6.38%
2011 145.67 Billion JPY -1.06%
2010 147.23 Billion JPY 7.32%
2009 137.19 Billion JPY 10.15%
2008 124.55 Billion JPY 1.76%
2007 122.39 Billion JPY -1.32%
2006 124.03 Billion JPY 2.47%
2005 121.04 Billion JPY 10.81%
2004 109.23 Billion JPY 0.0%

Peer Total Assets Comparison of KYORIN Holdings, Inc.

Name Total Assets Total Assets Difference
Pharma Foods International Co., Ltd. 36.57 Billion JPY -385.82%
Takeda Pharmaceutical Company Limited 15108.79 Billion JPY 98.824%
Sumitomo Pharma Co., Ltd. 907.5 Billion JPY 80.421%
Shionogi & Co., Ltd. 1416.91 Billion JPY 87.46%
Wakamoto Pharmaceutical Co.,Ltd. 15.42 Billion JPY -1052.185%
Nippon Shinyaku Co., Ltd. 263.4 Billion JPY 32.545%
Kaken Pharmaceutical Co., Ltd. 171.62 Billion JPY -3.529%
Eisai Co., Ltd. 1393.79 Billion JPY 87.252%
Morishita Jintan Co., Ltd. 17.18 Billion JPY -934.039%
Hisamitsu Pharmaceutical Co., Inc. 328.77 Billion JPY 45.958%
Mochida Pharmaceutical Co., Ltd. 158.8 Billion JPY -11.889%
Fuso Pharmaceutical Industries,Ltd. 76.46 Billion JPY -132.382%
Nippon Chemiphar Co., Ltd. 49.54 Billion JPY -258.6%
Tsumura & Co. 428.25 Billion JPY 58.511%
Kissei Pharmaceutical Co., Ltd. 260.92 Billion JPY 31.905%
Torii Pharmaceutical Co., Ltd. 133.43 Billion JPY -33.161%
Towa Pharmaceutical Co., Ltd. 430.65 Billion JPY 58.742%
Fuji Pharma Co., Ltd. 85.33 Billion JPY -108.221%
Zeria Pharmaceutical Co., Ltd. 150.53 Billion JPY -18.033%
Taiko Pharmaceutical Co.,Ltd. 15.04 Billion JPY -1080.905%
Daito Pharmaceutical Co.,Ltd. 77.7 Billion JPY -128.65%
SymBio Pharmaceuticals Limited 15.35 Billion JPY -1057.364%
MedRx Co., Ltd 2.05 Billion JPY -8558.821%
Mizuho Medy Co.,Ltd. 18.94 Billion JPY -837.703%
Solasia Pharma K.K. 2.55 Billion JPY -6867.804%
Modalis Therapeutics Corporation 2.02 Billion JPY -8670.265%
ASKA Pharmaceutical Holdings Co.,Ltd. 93.31 Billion JPY -90.414%
Sawai Group Holdings Co., Ltd. 382.02 Billion JPY 53.49%
Cyfuse Biomedical K.K. 4.21 Billion JPY -4115.588%
Toho Holdings Co., Ltd. 773.42 Billion JPY 77.027%
Koa Shoji Holdings Co.,Ltd. 32 Billion JPY -455.177%